VIVS Competitors & Alternatives

Compare VivoSim Labs, Inc. with similar stocks in the same industry

Biotechnology

VIVS

Main Stock
$0.29
+142.92%
Tradestie Score
36
Market Cap
$8.35M
Revenue Growth
-51.4%

Supply-Chain & Ecosystem Map (Customers, Suppliers & Direct Competitors)

Bottleneck Score: 1/10 Other
Competitive Moat: None
Major Customers 0
Diversified enterprise & commercial customer base.
Critical Suppliers 0
Internal vertical integration & multi-sourced components.
Direct Ecosystem Rivals 0
Sole-source / monopoly positioning in sub-sector.

Top Competitors

217 stocks in Biotechnology
Company Price Market Cap P/E Score Action
ACHV Achieve Life Sciences, Inc.
$6.78
+0.89%
$158.43M - 56 Compare
NVCT Nuvectis Pharma, Inc. Common Stock
$19.84
-2.22%
$154.27M - 52 Compare
OBIO Orchestra BioMed Holdings, Inc. Ordinary Shares
$7.00
-6.17%
$137.59M - 44 Compare
CLYM Climb Bio, Inc. Common Stock
$9.28
-0.22%
$133.50M - 44 Compare
SRZN Surrozen, Inc. Common
$30.67
-3.37%
$117.07M - 48 Compare
ANRO Alto Neuroscience Inc.
$26.51
+2.32%
$110.20M - 34 Compare
ENTX Entera Bio Ltd. Ordinary Shares
$3.28
+0.61%
$84.52M - 45 Compare
IMMX Immix Biopharma, Inc. Common Stock
$7.04
-0.98%
$67.94M - 57 Compare
INDP Indaptus Therapeutics, Inc. Common Stock
$3.13
-4.86%
$3.87M - 49 Compare
VJET VJET
$0.39
-6.28%
- - 47 Compare

Data updated: Nov 20, 2026 | Industry: Biotechnology (SIC 2836)

217 stocks in this industry